These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2899169)

  • 1. Regulation of the metabolism of striatal dynorphin by the dopaminergic system.
    Li SJ; Sivam SP; McGinty JF; Jiang HK; Douglass J; Calavetta L; Hong JS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):403-8. PubMed ID: 2899169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
    J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum.
    Li SJ; Jiang HK; Stachowiak MS; Hudson PM; Owyang V; Nanry K; Tilson HA; Hong JS
    Brain Res Mol Brain Res; 1990 Aug; 8(3):219-25. PubMed ID: 1977070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system.
    Li S; Sivam SP; Hong JS
    Brain Res; 1986 Nov; 398(2):390-2. PubMed ID: 2879611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
    Gerfen CR; McGinty JF; Young WS
    J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
    Sivam SP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.
    Carta AR; Tronci E; Pinna A; Morelli M
    Eur J Neurosci; 2005 Mar; 21(5):1196-204. PubMed ID: 15813929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
    Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
    Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
    Steiner H; Gerfen CR
    J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-dose and escalating-dose "binge" administration of cocaine alter expression of behavioral stereotypy and striatal preprodynorphin mRNA levels in rats.
    Schlussman SD; Zhou Y; Bailey A; Ho A; Kreek MJ
    Brain Res Bull; 2005 Oct; 67(3):169-75. PubMed ID: 16144651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of preprodynorphin mRNA in the spinal cord after inflammatory abdominal stimulation in rats].
    Nakamura F
    Hokkaido Igaku Zasshi; 1994 Jan; 69(1):95-103. PubMed ID: 7907075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats.
    Sivam SP; Takeuchi K; Li S; Douglass J; Civelli O; Calvetta L; Herbert E; McGinty JF; Hong JS
    Brain Res; 1988 Apr; 427(2):155-63. PubMed ID: 2898269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
    Trujillo KA; Day R; Akil H
    Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
    Sivam SP
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal.
    Isola R; Zhang H; Tejwani GA; Neff NH; Hadjiconstantinou M
    Synapse; 2008 Jun; 62(6):448-55. PubMed ID: 18361441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol.
    Sivam SP; Strunk C; Smith DR; Hong JS
    Mol Pharmacol; 1986 Aug; 30(2):186-91. PubMed ID: 3016502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of stimulant-induced preprodynorphin mRNA expression in the striatal matrix by serotonin depletion.
    Horner KA; Adams DH; Hanson GR; Keefe KA
    Neuroscience; 2005; 131(1):67-77. PubMed ID: 15680692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.